This is not the most recent version of the article. View current version (30 AUG 2013)

Intervention Review

Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

  1. Yvo B.W.E.M. Roos1,*,
  2. Gabriel JE Rinkel2,
  3. Marinus Vermeulen1,
  4. Ale Algra3,
  5. Jan van Gijn2

Editorial Group: Cochrane Stroke Group

Published Online: 22 APR 2003

Assessed as up-to-date: 6 FEB 2003

DOI: 10.1002/14651858.CD001245


How to Cite

Roos YB, Rinkel GJE, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD001245. DOI: 10.1002/14651858.CD001245.

Author Information

  1. 1

    Academic Medical Centre, Department of Neurology, Amsterdam, Netherlands

  2. 2

    University Medical Centre Utrecht, Department of Neurology, Utrecht, Netherlands

  3. 3

    University Medical Center Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands

*Yvo B.W.E.M. Roos, Department of Neurology, Academic Medical Centre, Meibergdreef 9, Amsterdam, 1105 AZ, Netherlands. y.b.roos@amc.uva.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 APR 2003

SEARCH

This is not the most recent version of the article. View current version (30 AUG 2013)

  1. You have free access to this content

    Current Version

    Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

    Merih I Baharoglu, Menno R Germans, Gabriel JE Rinkel, Ale Algra, Marinus Vermeulen, Jan van Gijn and Yvo BWEM Roos

    Version of Record online: 30 AUG 2013 | DOI: 10.1002/14651858.CD001245.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage

    Yvo B.W.E.M. Roos, Gabriel JE Rinkel, Marinus Vermeulen, Ale Algra and Jan van Gijn

    Version of Record online: 22 APR 2003 | DOI: 10.1002/14651858.CD001245